Header Logo

Christopher Seder

Concepts (363)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
35
2022
552
9.050
Why?
Carcinoma, Non-Small-Cell Lung
15
2021
243
5.420
Why?
Pneumonectomy
20
2022
77
5.260
Why?
Thoracic Surgery
14
2022
26
4.880
Why?
Esophageal Neoplasms
8
2022
50
3.700
Why?
Databases, Factual
13
2021
347
2.280
Why?
Societies, Medical
11
2020
121
2.130
Why?
Adenocarcinoma
8
2018
137
2.080
Why?
Thoracic Surgical Procedures
5
2019
9
1.780
Why?
Neoplasm Staging
13
2021
363
1.710
Why?
Humans
74
2023
27072
1.530
Why?
Thoracic Wall
3
2016
12
1.390
Why?
Postoperative Complications
8
2022
916
1.380
Why?
Quality Improvement
4
2019
138
1.340
Why?
Thoracic Surgery, Video-Assisted
7
2021
22
1.140
Why?
Neoplasm Recurrence, Local
3
2017
206
1.110
Why?
Biomarkers, Tumor
7
2022
205
1.090
Why?
Aged
33
2021
8997
1.040
Why?
Lung
5
2022
168
1.040
Why?
Neoplasms, Multiple Primary
2
2015
39
0.970
Why?
Female
39
2022
15212
0.930
Why?
Male
41
2022
14772
0.900
Why?
Cardiac Surgical Procedures
2
2016
35
0.870
Why?
Laparoscopy
3
2022
185
0.820
Why?
Colonic Neoplasms
3
2017
58
0.820
Why?
Biology
1
2022
8
0.810
Why?
Robotics
2
2013
25
0.800
Why?
Phosphoproteins
1
2022
26
0.800
Why?
Carcinoma, Adenoid Cystic
1
2022
3
0.780
Why?
Middle Aged
28
2022
8923
0.770
Why?
Registries
2
2021
189
0.740
Why?
Retrospective Studies
18
2022
3538
0.730
Why?
Advisory Committees
2
2018
19
0.720
Why?
Robotic Surgical Procedures
1
2021
33
0.720
Why?
Surgical Oncology
1
2020
6
0.710
Why?
Checklist
1
2020
33
0.680
Why?
Lymphadenopathy
1
2020
1
0.680
Why?
Prognosis
9
2022
785
0.680
Why?
Combined Modality Therapy
5
2020
300
0.660
Why?
Gases
1
2019
5
0.650
Why?
Intubation, Gastrointestinal
2
2010
11
0.650
Why?
Hate
1
2019
2
0.640
Why?
Chest Tubes
1
2019
3
0.640
Why?
Carcinoma, Squamous Cell
4
2019
172
0.640
Why?
Inhibin-beta Subunits
2
2009
2
0.640
Why?
Thoracotomy
3
2021
30
0.640
Why?
Catheter Ablation
1
2020
70
0.620
Why?
Clostridium Infections
2
2009
24
0.620
Why?
Enteral Nutrition
2
2010
66
0.620
Why?
Aged, 80 and over
15
2018
4777
0.610
Why?
Diaphragm
1
2018
8
0.590
Why?
Heart Diseases
2
2016
62
0.590
Why?
Mucous Membrane
1
2018
29
0.580
Why?
Foreign-Body Migration
1
2018
19
0.580
Why?
Scoliosis
1
2018
33
0.570
Why?
Risk Assessment
5
2019
624
0.560
Why?
Internationality
1
2017
21
0.560
Why?
Prosthesis Failure
2
2018
523
0.560
Why?
Databases as Topic
1
2017
14
0.560
Why?
Adult
16
2018
7831
0.550
Why?
Quality Assurance, Health Care
1
2017
30
0.550
Why?
Nurse Practitioners
1
2017
35
0.550
Why?
Benchmarking
1
2017
32
0.540
Why?
Ribs
1
2016
15
0.510
Why?
Cardiology
1
2016
44
0.510
Why?
Metformin
1
2016
17
0.510
Why?
Hypoglycemic Agents
1
2016
37
0.510
Why?
Pulmonary Blastoma
1
2015
4
0.500
Why?
United States
9
2021
2035
0.500
Why?
Mediastinal Neoplasms
1
2015
11
0.500
Why?
Testicular Neoplasms
1
2015
20
0.490
Why?
Neoplasm Invasiveness
4
2018
94
0.490
Why?
Academic Medical Centers
1
2016
132
0.490
Why?
Solitary Pulmonary Nodule
1
2015
14
0.480
Why?
Lung Diseases, Fungal
1
2015
10
0.480
Why?
Mucormycosis
1
2015
8
0.480
Why?
Early Medical Intervention
1
2015
14
0.480
Why?
Quality of Health Care
1
2016
102
0.470
Why?
Treatment Outcome
13
2021
3485
0.470
Why?
Survival Rate
7
2021
342
0.450
Why?
Practice Guidelines as Topic
1
2016
261
0.450
Why?
Surgical Mesh
1
2014
24
0.450
Why?
Risk Adjustment
3
2020
11
0.440
Why?
Manubrium
1
2014
2
0.440
Why?
Replantation
1
2014
10
0.440
Why?
Clavicle
1
2014
13
0.440
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
245
0.440
Why?
Herniorrhaphy
1
2014
36
0.440
Why?
Diabetes Mellitus, Type 2
1
2016
167
0.430
Why?
Esophagectomy
3
2022
23
0.410
Why?
Tricuspid Valve Prolapse
1
2012
1
0.410
Why?
Mitral Valve Annuloplasty
1
2012
1
0.410
Why?
Prostheses and Implants
1
2014
154
0.400
Why?
Heart Valve Prosthesis Implantation
1
2012
25
0.390
Why?
Breast Neoplasms
2
2017
409
0.390
Why?
Surgery, Computer-Assisted
1
2012
49
0.390
Why?
Cell Line, Tumor
4
2022
256
0.370
Why?
Tomography, X-Ray Computed
6
2018
683
0.370
Why?
Spinal Fusion
1
2018
457
0.360
Why?
Survival Analysis
3
2018
257
0.360
Why?
Simulation Training
2
2021
39
0.350
Why?
Myxoma
1
2010
4
0.350
Why?
Mitral Valve
1
2010
9
0.340
Why?
Heart Neoplasms
1
2010
12
0.340
Why?
Neoadjuvant Therapy
3
2022
65
0.340
Why?
Energy Intake
1
2010
83
0.330
Why?
Aneurysm, Infected
1
2009
1
0.320
Why?
Clostridium septicum
1
2009
1
0.320
Why?
Aortitis
1
2009
2
0.320
Why?
Embolism
1
2009
3
0.320
Why?
Embolectomy
1
2009
3
0.320
Why?
Gene Expression Regulation, Neoplastic
2
2009
116
0.320
Why?
Mesenteric Vascular Occlusion
1
2009
3
0.320
Why?
Blood Component Transfusion
1
2009
4
0.320
Why?
Jehovah's Witnesses
1
2009
3
0.320
Why?
Treatment Refusal
1
2009
11
0.320
Why?
Aortic Aneurysm
1
2009
12
0.320
Why?
Length of Stay
4
2016
313
0.320
Why?
Ischemia
1
2009
24
0.320
Why?
Enterocolitis, Pseudomembranous
1
2009
12
0.310
Why?
Blood Vessel Prosthesis Implantation
3
2018
20
0.310
Why?
Religion and Medicine
1
2009
25
0.310
Why?
Intraoperative Complications
1
2009
63
0.310
Why?
Bronchoscopy
3
2019
33
0.310
Why?
Critical Care
1
2010
117
0.300
Why?
Internship and Residency
3
2018
211
0.300
Why?
Risk Factors
4
2022
2302
0.300
Why?
Epigenesis, Genetic
1
2009
83
0.300
Why?
Surgeons
2
2020
87
0.300
Why?
Hospital Costs
1
2008
59
0.290
Why?
Education, Medical, Graduate
2
2020
77
0.290
Why?
Sarcoma
2
2021
147
0.270
Why?
Intensive Care Units
1
2008
261
0.260
Why?
Disease-Free Survival
2
2017
174
0.260
Why?
Trachea
2
2022
46
0.260
Why?
Follow-Up Studies
5
2021
1792
0.260
Why?
Clinical Competence
3
2020
206
0.260
Why?
Early Detection of Cancer
4
2022
102
0.240
Why?
Neovascularization, Pathologic
2
2015
37
0.240
Why?
Biomarkers
2
2017
562
0.230
Why?
Surgical Flaps
2
2015
49
0.220
Why?
Chemoradiotherapy
2
2015
61
0.220
Why?
Embolism, Air
1
2023
10
0.220
Why?
Consensus
2
2021
87
0.220
Why?
Bronchi
2
2015
12
0.210
Why?
Thymoma
2
2020
7
0.200
Why?
Thrombosis
1
2023
54
0.200
Why?
Computer Simulation
2
2021
195
0.200
Why?
Blood Coagulation Disorders
1
2022
14
0.200
Why?
Hemostatics
1
2022
10
0.200
Why?
Thymus Neoplasms
2
2020
12
0.200
Why?
Carbon Monoxide
1
2022
6
0.200
Why?
Intubation, Intratracheal
2
2016
94
0.190
Why?
Lymph Nodes
2
2020
72
0.190
Why?
Metastasectomy
1
2021
7
0.190
Why?
Programmed Cell Death 1 Receptor
1
2022
18
0.190
Why?
Cohort Studies
4
2018
1890
0.190
Why?
Multivariate Analysis
3
2017
329
0.190
Why?
Ventricular Dysfunction, Right
1
2021
9
0.180
Why?
Patient Discharge
1
2022
158
0.180
Why?
Heart-Assist Devices
1
2021
19
0.180
Why?
Incidence
2
2021
759
0.180
Why?
Mass Screening
2
2022
167
0.170
Why?
Mediastinal Cyst
1
2020
1
0.170
Why?
RNA, Messenger
3
2009
310
0.160
Why?
Carcinoma
2
2017
67
0.160
Why?
Smoking
1
2020
176
0.160
Why?
Small Cell Lung Carcinoma
1
2019
7
0.160
Why?
Ultrasonography, Interventional
1
2020
69
0.160
Why?
False Positive Reactions
1
2019
34
0.160
Why?
Heart Failure
1
2021
151
0.160
Why?
Drainage
1
2019
39
0.160
Why?
Sensitivity and Specificity
4
2018
482
0.160
Why?
Insulin-Like Growth Factor I
2
2022
59
0.160
Why?
RNA, Small Interfering
2
2009
81
0.160
Why?
Unnecessary Procedures
1
2019
27
0.150
Why?
Kaplan-Meier Estimate
2
2009
175
0.150
Why?
Thoracoscopy
3
2019
22
0.150
Why?
Randomized Controlled Trials as Topic
1
2020
292
0.150
Why?
Obesity
1
2021
311
0.150
Why?
Aortic Aneurysm, Thoracic
1
2018
10
0.150
Why?
Cell Proliferation
2
2009
175
0.150
Why?
Histocompatibility Antigens Class II
1
2018
6
0.150
Why?
HLA Antigens
1
2018
14
0.150
Why?
Hemoptysis
1
2018
7
0.150
Why?
Histocompatibility Antigens Class I
1
2018
14
0.150
Why?
Multiple Pulmonary Nodules
1
2018
11
0.150
Why?
Syndecan-1
1
2018
5
0.150
Why?
Immunohistochemistry
2
2009
366
0.150
Why?
Radiography, Thoracic
1
2018
27
0.150
Why?
Chest Pain
1
2018
19
0.150
Why?
Diagnosis, Differential
2
2018
348
0.140
Why?
Morbidity
2
2019
54
0.140
Why?
Immunoassay
1
2018
38
0.140
Why?
Nerve Growth Factors
1
2018
38
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
11
0.140
Why?
Bronchial Neoplasms
1
2017
5
0.140
Why?
Airway Obstruction
1
2017
20
0.140
Why?
Suture Techniques
1
2018
157
0.140
Why?
Lymphoma
1
2017
35
0.140
Why?
History, 19th Century
1
2016
5
0.130
Why?
History, 21st Century
1
2016
19
0.130
Why?
History, 20th Century
1
2016
31
0.130
Why?
Diffusion of Innovation
1
2016
24
0.130
Why?
Stents
1
2017
82
0.130
Why?
Biopsy
1
2017
201
0.130
Why?
Melanoma
1
2017
60
0.130
Why?
Adolescent
1
2022
2172
0.130
Why?
Pulmonary Diffusing Capacity
1
2016
8
0.130
Why?
Pneumonia, Bacterial
1
2016
11
0.130
Why?
Europe
1
2016
58
0.130
Why?
Tracheostomy
1
2016
25
0.130
Why?
Minimally Invasive Surgical Procedures
2
2010
313
0.130
Why?
Prospective Studies
1
2021
1778
0.130
Why?
Etoposide
1
2015
27
0.130
Why?
Ifosfamide
1
2015
14
0.130
Why?
Models, Statistical
1
2016
127
0.120
Why?
Cisplatin
1
2015
58
0.120
Why?
Time Factors
1
2019
1433
0.120
Why?
Thymus Gland
1
2015
11
0.120
Why?
Proportional Hazards Models
1
2016
347
0.120
Why?
Diabetes Mellitus
1
2016
127
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
10
0.120
Why?
Comorbidity
1
2016
481
0.110
Why?
Thoracic Cavity
1
2014
1
0.110
Why?
Antineoplastic Agents
1
2016
198
0.110
Why?
Thoracic Neoplasms
1
2014
9
0.110
Why?
Chicago
1
2016
949
0.110
Why?
Mediastinum
1
2013
6
0.110
Why?
Hernia, Hiatal
1
2013
13
0.100
Why?
Fatal Outcome
2
2011
54
0.100
Why?
Tricuspid Valve Insufficiency
1
2012
2
0.100
Why?
Histone Acetyltransferases
2
2009
4
0.100
Why?
Acetylation
2
2009
14
0.100
Why?
Histone Deacetylases
2
2009
11
0.100
Why?
Dyspnea
1
2012
41
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2009
57
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
137
0.100
Why?
Age Factors
2
2016
766
0.090
Why?
Fistula
1
2011
2
0.090
Why?
Gastric Fistula
1
2011
5
0.090
Why?
Anastomotic Leak
1
2011
6
0.090
Why?
Living Donors
1
2011
16
0.090
Why?
Lung Transplantation
1
2011
13
0.090
Why?
Continuous Positive Airway Pressure
1
2011
23
0.090
Why?
Postoperative Hemorrhage
1
2011
23
0.090
Why?
Tissue and Organ Procurement
1
2011
37
0.090
Why?
Graft Rejection
1
2011
68
0.090
Why?
Sutures
1
2011
53
0.090
Why?
Endoleak
1
2010
1
0.090
Why?
Aortic Aneurysm, Abdominal
1
2010
3
0.090
Why?
Chordae Tendineae
1
2010
1
0.090
Why?
Blood Pressure Determination
1
2010
14
0.090
Why?
Blood Vessel Prosthesis
1
2010
13
0.090
Why?
Monitoring, Intraoperative
1
2010
35
0.090
Why?
Surgical Tape
1
2010
3
0.090
Why?
Conscious Sedation
1
2010
5
0.080
Why?
Glasgow Coma Scale
1
2010
8
0.080
Why?
APACHE
1
2010
27
0.080
Why?
Endovascular Procedures
1
2010
33
0.080
Why?
Equipment Failure
1
2010
38
0.080
Why?
Gastric Bypass
1
2011
69
0.080
Why?
Heart Ventricles
1
2010
92
0.080
Why?
Activins
1
2009
1
0.080
Why?
Follistatin
1
2009
1
0.080
Why?
Mesenteric Artery, Superior
1
2009
2
0.080
Why?
Tissue Array Analysis
1
2009
7
0.080
Why?
Probability
1
2009
88
0.080
Why?
Iliac Artery
1
2009
5
0.080
Why?
Statistics, Nonparametric
1
2009
125
0.080
Why?
Blood Pressure
1
2010
195
0.080
Why?
Multiple Organ Failure
1
2009
17
0.080
Why?
Aorta
1
2009
17
0.080
Why?
Digestive System Surgical Procedures
1
2009
24
0.080
Why?
Histones
1
2009
32
0.080
Why?
Cattle
1
2009
130
0.080
Why?
Transfection
1
2009
121
0.080
Why?
Blotting, Western
1
2009
147
0.080
Why?
Histone Deacetylase Inhibitors
1
2008
7
0.080
Why?
Promoter Regions, Genetic
1
2009
93
0.080
Why?
Safety
1
2008
37
0.080
Why?
Debridement
1
2009
100
0.080
Why?
Acute Disease
1
2009
176
0.080
Why?
Glycoproteins
1
2008
47
0.080
Why?
Cost-Benefit Analysis
1
2008
123
0.070
Why?
Enzyme Inhibitors
1
2008
114
0.070
Why?
Anticoagulants
1
2009
87
0.070
Why?
Recurrence
1
2009
310
0.070
Why?
Carrier Proteins
1
2008
102
0.070
Why?
Up-Regulation
1
2009
170
0.070
Why?
Autoantibodies
1
2008
80
0.070
Why?
DNA Methylation
1
2009
161
0.070
Why?
Anti-Bacterial Agents
1
2009
370
0.060
Why?
Magnetic Resonance Imaging
1
2010
1112
0.060
Why?
Reproducibility of Results
2
2019
676
0.060
Why?
Iatrogenic Disease
1
2023
25
0.050
Why?
Thrombelastography
1
2022
5
0.050
Why?
Blood Coagulation Tests
1
2022
11
0.050
Why?
Hemostasis
1
2022
9
0.050
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.050
Why?
Hemorrhage
1
2022
81
0.050
Why?
Tumor Microenvironment
1
2022
20
0.050
Why?
Inflammation
1
2023
272
0.050
Why?
Animals
1
2009
3642
0.050
Why?
Predictive Value of Tests
2
2014
474
0.050
Why?
Equipment Design
2
2011
138
0.040
Why?
Young Adult
2
2017
1994
0.040
Why?
Mediastinoscopy
1
2019
6
0.040
Why?
Hemolysis
1
2018
5
0.040
Why?
North America
1
2018
41
0.040
Why?
Canada
1
2018
47
0.040
Why?
Magnetic Resonance Angiography
1
2018
29
0.040
Why?
Pneumonia
1
2019
67
0.040
Why?
Carcinoma, Embryonal
1
2017
3
0.040
Why?
Dilatation
1
2017
10
0.040
Why?
Tonsillar Neoplasms
1
2017
3
0.040
Why?
Leiomyosarcoma
1
2017
21
0.030
Why?
Carcinoma, Renal Cell
1
2017
46
0.030
Why?
Propensity Score
1
2016
36
0.030
Why?
Kidney Neoplasms
1
2017
78
0.030
Why?
Skin Neoplasms
1
2017
80
0.030
Why?
Neoplasm, Residual
1
2015
7
0.030
Why?
Practice Patterns, Physicians'
1
2016
111
0.030
Why?
Lymph Node Excision
1
2015
27
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
Why?
Radiotherapy Dosage
1
2015
99
0.030
Why?
Minnesota
1
2014
6
0.030
Why?
Sex Factors
1
2016
464
0.030
Why?
Analysis of Variance
1
2015
260
0.030
Why?
Area Under Curve
1
2014
63
0.030
Why?
Postoperative Period
1
2016
333
0.030
Why?
ROC Curve
1
2014
141
0.030
Why?
Patient Readmission
1
2015
129
0.030
Why?
Illinois
1
2014
250
0.030
Why?
Cytokines
1
2014
222
0.030
Why?
Algorithms
1
2014
350
0.020
Why?
Disease Progression
1
2014
673
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
4
0.020
Why?
Proton Pump Inhibitors
1
2011
10
0.020
Why?
Esophageal Perforation
1
2011
8
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
23
0.020
Why?
Candidiasis
1
2011
24
0.020
Why?
Pulmonary Gas Exchange
1
2011
7
0.020
Why?
Surgical Stapling
1
2011
5
0.020
Why?
Constriction, Pathologic
1
2011
33
0.020
Why?
Graft Survival
1
2011
97
0.020
Why?
Transducers, Pressure
1
2010
4
0.020
Why?
Aortography
1
2010
6
0.020
Why?
Respiration, Artificial
1
2011
104
0.020
Why?
Rupture
1
2010
110
0.020
Why?
Obesity, Morbid
1
2011
105
0.020
Why?
Hydroxamic Acids
1
2008
4
0.020
Why?
Immunoenzyme Techniques
1
2008
31
0.020
Why?
Adipokines
1
2008
7
0.020
Why?
Azacitidine
1
2008
10
0.020
Why?
Tumor Cells, Cultured
1
2008
129
0.020
Why?
Gene Expression Profiling
1
2008
139
0.020
Why?
Reoperation
1
2011
925
0.020
Why?
Case-Control Studies
1
2008
587
0.020
Why?
Seder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_